Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Revised Interpretation of the Hain Lifescience GenoType MTBC To Differentiate Mycobacterium canettii and Members of the Mycobacterium tuberculosis Complex.

Loiseau C, Brites D, Moser I, Coll F, Pourcel C, Robbe-Austerman S, Escuyer V, Musser KA, Peacock SJ, Feuerriegel S, Kohl TA, Niemann S, Gagneux S, Köser CU.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e00159-19. doi: 10.1128/AAC.00159-19. Print 2019 Jun.

2.

Using Reduced Inoculum Densities of Mycobacterium tuberculosis in MGIT Pyrazinamide Susceptibility Testing to Prevent False-Resistant Results and Improve Accuracy: A Multicenter Evaluation.

Morlock GP, Tyrrell FC, Baynham D, Escuyer VE, Green N, Kim Y, Longley-Olson PA, Parrish N, Pennington C, Tan D, Austin B, Posey JE.

Tuberc Res Treat. 2017;2017:3748163. doi: 10.1155/2017/3748163. Epub 2017 Nov 8.

3.

Mycobacterium orygis Lymphadenitis in New York, USA.

Marcos LA, Spitzer ED, Mahapatra R, Ma Y, Halse TA, Shea J, Isabelle M, Lapierre P, Escuyer VE.

Emerg Infect Dis. 2017 Oct;23(10):1749-1751. doi: 10.3201/eid2310.170490.

4.

Comprehensive Whole-Genome Sequencing and Reporting of Drug Resistance Profiles on Clinical Cases of Mycobacterium tuberculosis in New York State.

Shea J, Halse TA, Lapierre P, Shudt M, Kohlerschmidt D, Van Roey P, Limberger R, Taylor J, Escuyer V, Musser KA.

J Clin Microbiol. 2017 Jun;55(6):1871-1882. doi: 10.1128/JCM.00298-17. Epub 2017 Apr 5.

5.

Performance of the G4 Xpert® MTB/RIF assay for the detection of Mycobacterium tuberculosis and rifampin resistance: a retrospective case-control study of analytical and clinical samples from high- and low-tuberculosis prevalence settings.

Dharan NJ, Blakemore R, Sloutsky A, Kaur D, Alexander RC, Ghajar M, Musser KA, Escuyer VE, Rowlinson MC, Crowe S, Laniado-Laborin R, Valli E, Nabeta P, Johnson P, Alland D.

BMC Infect Dis. 2016 Dec 20;16(1):764.

6.

Within Host Evolution Selects for a Dominant Genotype of Mycobacterium tuberculosis while T Cells Increase Pathogen Genetic Diversity.

Copin R, Wang X, Louie E, Escuyer V, Coscolla M, Gagneux S, Palmer GH, Ernst JD.

PLoS Pathog. 2016 Dec 14;12(12):e1006111. doi: 10.1371/journal.ppat.1006111. eCollection 2016 Dec.

7.

Draft Genome Sequence of Branchiibius sp. NY16-3462-2, Isolated from a Mixed Clinical Sample.

Lapierre P, Halse TA, Shea J, Escuyer VE, Musser KA.

Genome Announc. 2016 May 12;4(3). pii: e00368-16. doi: 10.1128/genomeA.00368-16.

8.

A Model of Shared Mycobacteriology Testing Services: Lessons Learned.

Mitchell K, Halse T, Kohlerschmidt D, Bennett T, Vanner C, King E, Musser K, Escuyer V.

Public Health Rep. 2015 Nov-Dec;130(6):623-31.

9.

Rapid prediction of inducible clarithromycin resistance in Mycobacterium abscessus.

Zhu YC, Mitchell KK, Nazarian EJ, Escuyer VE, Musser KA.

Mol Cell Probes. 2015 Dec;29(6):514-516. doi: 10.1016/j.mcp.2015.08.007. Epub 2015 Sep 1.

PMID:
26334290
10.

Whole Genome Sequencing Investigation of a Tuberculosis Outbreak in Port-au-Prince, Haiti Caused by a Strain with a "Low-Level" rpoB Mutation L511P - Insights into a Mechanism of Resistance Escalation.

Ocheretina O, Shen L, Escuyer VE, Mabou MM, Royal-Mardi G, Collins SE, Pape JW, Fitzgerald DW.

PLoS One. 2015 Jun 3;10(6):e0129207. doi: 10.1371/journal.pone.0129207. eCollection 2015.

11.

Multilocus sequence typing of Mycobacterium xenopi.

Alexander DC, Marras TK, Ma JH, Mirza S, Liu D, Kus JV, Soualhine H, Escuyer V, Warshauer D, Brode SK, Farrell DJ, Jamieson FB.

J Clin Microbiol. 2014 Nov;52(11):3973-7. doi: 10.1128/JCM.01601-14. Epub 2014 Sep 10.

12.

Detection of Mycobacterium avium complex DNA directly in clinical respiratory specimens: opportunities for improved turn-around time and cost savings.

Tran AC, Halse TA, Escuyer VE, Musser KA.

Diagn Microbiol Infect Dis. 2014 May;79(1):43-8. doi: 10.1016/j.diagmicrobio.2014.01.019. Epub 2014 Jan 30.

PMID:
24612561
13.

Correlation between genotypic and phenotypic testing for resistance to rifampin in Mycobacterium tuberculosis clinical isolates in Haiti: investigation of cases with discrepant susceptibility results.

Ocheretina O, Escuyer VE, Mabou MM, Royal-Mardi G, Collins S, Vilbrun SC, Pape JW, Fitzgerald DW.

PLoS One. 2014 Mar 5;9(3):e90569. doi: 10.1371/journal.pone.0090569. eCollection 2014.

14.

Use of Luminex MagPlex magnetic microspheres for high-throughput spoligotyping of Mycobacterium tuberculosis isolates in Port-au-Prince, Haiti.

Ocheretina O, Merveille YM, Mabou MM, Escuyer VE, Dunbar SA, Johnson WD, Pape JW, Fitzgerald DW.

J Clin Microbiol. 2013 Jul;51(7):2232-7. doi: 10.1128/JCM.00268-13. Epub 2013 May 8.

15.

Outbreak of Mycobacterium chelonae infection associated with tattoo ink.

Kennedy BS, Bedard B, Younge M, Tuttle D, Ammerman E, Ricci J, Doniger AS, Escuyer VE, Mitchell K, Noble-Wang JA, O'Connell HA, Lanier WA, Katz LM, Betts RF, Mercurio MG, Scott GA, Lewis MA, Goldgeier MH.

N Engl J Med. 2012 Sep 13;367(11):1020-4. doi: 10.1056/NEJMoa1205114. Epub 2012 Aug 22.

16.

Multidrug-resistant tuberculosis in Port-au-Prince, Haiti.

Ocheretina O, Morose W, Gauthier M, Joseph P, D'Meza R, Escuyer VE, Rastogi N, Vernet G, Pape JW, Fitzgerald DW.

Rev Panam Salud Publica. 2012 Mar;31(3):221-4.

17.

Evaluation of a single-tube multiplex real-time PCR for differentiation of members of the Mycobacterium tuberculosis complex in clinical specimens.

Halse TA, Escuyer VE, Musser KA.

J Clin Microbiol. 2011 Jul;49(7):2562-7. doi: 10.1128/JCM.00467-11. Epub 2011 May 18.

18.

Combined real-time PCR and rpoB gene pyrosequencing for rapid identification of Mycobacterium tuberculosis and determination of rifampin resistance directly in clinical specimens.

Halse TA, Edwards J, Cunningham PL, Wolfgang WJ, Dumas NB, Escuyer VE, Musser KA.

J Clin Microbiol. 2010 Apr;48(4):1182-8. doi: 10.1128/JCM.02149-09. Epub 2010 Jan 27.

19.

Overexpression, purification and crystallographic analysis of a unique adenosine kinase from Mycobacterium tuberculosis.

Wang Y, Long MC, Ranganathan S, Escuyer V, Parker WB, Li R.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2005 Jun 1;61(Pt 6):553-7. Epub 2005 Jun 1.

20.

Cloning, expression, and characterization of Mycobacterium tuberculosis dihydrofolate reductase.

White EL, Ross LJ, Cunningham A, Escuyer V.

FEMS Microbiol Lett. 2004 Mar 12;232(1):101-5.

21.
22.

The Emb proteins of mycobacteria direct arabinosylation of lipoarabinomannan and arabinogalactan via an N-terminal recognition region and a C-terminal synthetic region.

Zhang N, Torrelles JB, McNeil MR, Escuyer VE, Khoo KH, Brennan PJ, Chatterjee D.

Mol Microbiol. 2003 Oct;50(1):69-76.

23.

Yersinia pseudotuberculosis harbors a type IV pilus gene cluster that contributes to pathogenicity.

Collyn F, Léty MA, Nair S, Escuyer V, Ben Younes A, Simonet M, Marceau M.

Infect Immun. 2002 Nov;70(11):6196-205.

24.

Emerging therapeutic targets in tuberculosis: post-genomic era.

Khasnobis S, Escuyer VE, Chatterjee D.

Expert Opin Ther Targets. 2002 Feb;6(1):21-40. Review.

PMID:
11901479
25.

The role of the embA and embB gene products in the biosynthesis of the terminal hexaarabinofuranosyl motif of Mycobacterium smegmatis arabinogalactan.

Escuyer VE, Lety MA, Torrelles JB, Khoo KH, Tang JB, Rithner CD, Frehel C, McNeil MR, Brennan PJ, Chatterjee D.

J Biol Chem. 2001 Dec 28;276(52):48854-62. Epub 2001 Oct 24.

26.

ClpE, a novel member of the HSP100 family, is involved in cell division and virulence of Listeria monocytogenes.

Nair S, Frehel C, Nguyen L, Escuyer V, Berche P.

Mol Microbiol. 1999 Jan;31(1):185-96.

27.

A single point mutation in the embB gene is responsible for resistance to ethambutol in Mycobacterium smegmatis.

Lety MA, Nair S, Berche P, Escuyer V.

Antimicrob Agents Chemother. 1997 Dec;41(12):2629-33.

28.

The rfaD locus: a region of rearrangement in Vibrio cholerae O139.

Vimont S, Dumontier S, Escuyer V, Berche P.

Gene. 1997 Jan 31;185(1):43-7.

PMID:
9034311
29.

Molecular characterization of a surface-exposed superoxide dismutase of Mycobacterium avium.

Escuyer V, Haddad N, Frehel C, Berche P.

Microb Pathog. 1996 Jan;20(1):41-55.

PMID:
8692009
30.

Mercury resistance as a selective marker for recombinant mycobacteria.

Baulard A, Escuyer V, Haddad N, Kremer L, Locht C, Berche P.

Microbiology. 1995 Apr;141 ( Pt 4):1045-50.

PMID:
7773382
31.

Reversion of recombinant toxoids: mutations in diphtheria toxin that partially compensate for active-site deletions.

Killeen KP, Escuyer V, Mekalanos JJ, Collier RJ.

Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):6207-9.

32.
33.

Immunity protein is not required for the bactericidal activity of colicin E3.

Escuyer V, Perrin D, Mock M.

Mol Microbiol. 1989 Jun;3(6):807-12.

PMID:
2664424
34.

Structural homology between virulence-associated bacterial adenylate cyclases.

Escuyer V, Duflot E, Sezer O, Danchin A, Mock M.

Gene. 1988 Nov 30;71(2):293-8.

PMID:
2906312
35.
36.

A pH-induced increase in hydrophobicity as a possible step in the penetration of colicin E3 through bacterial membranes.

Escuyer V, Boquet P, Perrin D, Montecucco C, Mock M.

J Biol Chem. 1986 Aug 15;261(23):10891-8.

Supplemental Content

Loading ...
Support Center